FDA
-
-
-
-
-
-
-
ABIONYX decides on a capital increase with cancellation of preferential subscription rights for the benefit of a category of persons through the issue of shares with warrants for an amount of c.€3.4
-
-
-
-
-
327,059 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

